Orangetheory vs Uncommon Therapeutics

Side-by-side comparison of AI visibility scores, market position, and capabilities

Orangetheory leads in AI visibility (68 vs 27)

Orangetheory

LeaderFitness & Wellness

Fitness Studio

Fort Lauderdale heart rate-monitored interval training franchise with 1,500+ studios and 1.5M+ members; $400M raised competing with F45 and Barry's for boutique fitness at $59-$159/month technology-tracked group workouts.

AI VisibilityBeta
Overall Score
B68
Category Rank
#1 of 3
AI Consensus
75%
Trend
stable
Per Platform
ChatGPT
72
Perplexity
63
Gemini
67

About

Orangetheory Fitness is a Fort Lauderdale-based boutique fitness franchise delivering science-based, heart rate-monitored group interval training workouts — 60-minute sessions combining treadmill cardio, rowing, and weight-training floor work structured around heart rate zones displayed on studio monitors, targeting the "Orange Zone" (84-91% max heart rate) that produces excess post-exercise oxygen consumption (EPOC) for extended calorie burn. Founded in 2010 by Ellen Latham and backed with $400 million raised, Orangetheory operates 1,500+ franchise studios across 25+ countries serving over 1.5 million members paying $59-$159/month for membership plans.

Full profile

Uncommon Therapeutics

EmergingHealthcare

General

Rare disease biotech developing polytherapy approach for Rett Syndrome (1 in 10,000 girls); founder-developed protocol validated through personal patient experience competing with Acadia Pharmaceuticals Daybue in Rett market.

AI VisibilityBeta
Overall Score
D27
Category Rank
#1121 of 1167
AI Consensus
67%
Trend
stable
Per Platform
ChatGPT
28
Perplexity
33
Gemini
36

About

Uncommon Therapeutics is a biotech company founded by Noah Auerhahn — directly inspired by his daughter's diagnosis with Rett Syndrome, a severe genetic neurological disease affecting approximately 1 in 10,000 girls — applying a polytherapy approach (combining multiple therapeutic agents targeting different disease mechanisms simultaneously) to develop treatments for serious neurological and rare diseases. After improving his daughter's quality of life through a personally developed polytherapy protocol, Auerhahn founded Uncommon Therapeutics to translate these insights into pharmaceutical products for the broader Rett Syndrome patient community.

Full profile

AI Visibility Head-to-Head

68
Overall Score
27
#1
Category Rank
#1121
75
AI Consensus
67
stable
Trend
stable
72
ChatGPT
28
63
Perplexity
33
67
Gemini
36
67
Claude
22
73
Grok
33

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.